ACACA and obesity due to melanocortin 4 receptor deficiency: For many years, the key regulatory role of ACC1 in fatty acid metabolism makes it attractive therapeutic targets for various metabolic diseases including non-alcoholic fatty liver disease, obesity and diabetes.